425: Strive, Semler Scientific Merger Update

Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. filed a Form 425 communication on December 31, 2025, related to its proposed business combination with Semler Scientific, Inc.
• The communication was posted on X.com by Matthew Cole, CEO of Strive, in connection with the proposed merger.
• The filing includes a cautionary statement regarding forward-looking statements concerning the proposed transaction, its strategic and financial benefits, timing, and integration.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus for important information about the companies and the proposed transaction.
• Strive and Semler Scientific, along with their respective directors, executive officers, and employees, may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it is not an offer to sell or a solicitation of an offer to sell or buy any securities, nor a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a standard regulatory communication about a proposed merger, primarily focused on risk disclosure and procedural information. It reiterates the potential benefits but heavily emphasizes the uncertainties and risks, leading to a neutral sentiment.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the merger.

Negatives

• Diversion of management's attention from ongoing business operations and opportunities is a potential consequence.
• Dilution caused by Strive's issuance of additional Class A common stock in connection with the proposed transaction is expected.
• Potential adverse reactions from Strive's or Semler Scientific's customers are a concern.
• Possible changes to business or employee relationships may result from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing could occur.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the realization of benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• Other factors, including unknown or unpredictable factors, also could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing contains forward-looking statements regarding the proposed transaction, including expectations for strategic and financial benefits, the timing of closing, and the successful integration of the combined businesses. However, these statements are subject to significant risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.

Industry Context

This filing is a procedural communication related to a proposed merger, and as such, it does not provide specific details that allow for an analysis of broader industry trends or competitive landscape. The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests involvement in or exposure to the digital asset space, which is a growing area of interest and volatility.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Stakeholder Impact

• Shareholders: Potential dilution due to Strive's issuance of additional shares of Class A common stock.
• Customers: Potential adverse reactions from Strive's or Semler Scientific's customers.
• Employees: Potential changes to business or employee relationships.

Next Steps

• Stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus.
• Semler Scientific stockholders need to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Keywords

Strive Inc., Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Corporate Governance, Risk Factors, Stockholder Approval, Bitcoin Treasury Strategy, Digital Assets